Lophora

Lophora is at the forefront of biotechnology research, dedicated to developing next-generation psychedelic medicines aimed at revolutionizing the treatment of mental illnesses. With a strong focus on CNS drug discovery, Lophora is committed to addressing a multitude of psychiatric disorders through innovative pharmaceutical solutions.

Based in Gentofte, Capital Region of Denmark, at Gyldenlundsvej 21, Lophora's research and development efforts are driven by a mission to improve mental health outcomes. The company leverages cutting-edge science and rigorous clinical trials to ensure the efficacy and safety of its novel treatments. An additional location at Ole Maaløes Vej 3 in Copenhagen further supports Lophora’s expansive research endeavors.

Lophora is diligently working to expand its impact on the biotechnology landscape. Management is continuously refining and updating company information to showcase its advancements and capabilities. We invite the manager of Lophora to create a customized and exclusive company showcase and product listing on our platform to further enhance its market presence.